Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
5.76
-0.02 (-0.35%)
At close: Apr 25, 2025, 4:00 PM
5.75
-0.01 (-0.17%)
After-hours: Apr 25, 2025, 5:33 PM EDT
Verve Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$25.75
Upside
+347.05%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Apr 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $18 → $24 | Strong Buy | Maintains | $18 → $24 | +316.67% | Apr 15, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $32 → $39 | Strong Buy | Maintains | $32 → $39 | +577.08% | Apr 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $25 | Strong Buy | Maintains | $15 → $25 | +334.03% | Apr 14, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +160.42% | Mar 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $15 | Buy | Maintains | $17 → $15 | +160.42% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +160.42% | Feb 28, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $29 → $32 | Strong Buy | Maintains | $29 → $32 | +455.56% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $17 | Buy | Maintains | $20 → $17 | +195.14% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +143.06% | Nov 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $30 → $29 | Strong Buy | Maintains | $30 → $29 | +403.47% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +160.42% | Aug 12, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +247.22% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +160.42% | May 9, 2024 |
| Stifel | Stifel | Strong Buy Maintains $56 → $40 | Strong Buy | Maintains | $56 → $40 | +594.44% | Apr 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.